Sept 27 (Reuters) - WW International ( WW ), also known

as WeightWatchers, said on Friday CEO Sima Sistani was stepping

down and that insider Tara Comonte would succeed her on an

interim basis.

During Sistani's two-and-a-half-year tenure, WeightWatchers

in 2023 acquired the telehealth platform Sequence, now known as

WeightWatchers Clinic, expanding into obesity drug

prescriptions.

Despite this, the company's shares have plummeted about 90%

this year due to the rising popularity of GLP-1 drugs like

Ozempic and Wegovy, which have impacted its traditional weight

loss program.

In February, the company's stock took another hit after it

disclosed that celebrity shareholder Oprah Winfrey would exit

its board and donate her stock to the National Museum of African

American History and Culture.

Comonte joined the WeightWatchers' board in June last year.

She previously served as CEO of TMRW Life Sciences, after

working as a President and finance chief at fast-food chain

Shake Shack ( SHAK ).

The company also reaffirmed its prior full-year 2024

forecast for revenue as well as adjusted operating income on

Friday.